Home › NDC Lookup › RxCUI directory › RxCUI 2055286

Loteprednol etabonate 10 MG/ML Ophthalmic Suspension [Inveltys] — RxCUI 2055286

RxNorm drug concept · Semantic branded drug
RxCUI 2055286 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2055286
Official nameLoteprednol etabonate 10 MG/ML Ophthalmic Suspension [Inveltys]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asInveltys 1 % Ophthalmic Suspension; Inveltys 10 MG/ML Ophthalmic Suspension
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)106 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Loteprednol Etabonate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on which product you've been given. Some versions — like Alrex — treat seasonal eye allergies. Eysuvis is used short-term for dry eye disease. Others, like Inveltys and...
  • What is loteprednol etabonate actually used for?
  • Always wash your hands before touching your eyes or the bottle. Shake the bottle as directed — the shaking instructions are slightly different for each product, so check your label...
  • That depends on your condition and which product you're using. For post-surgical use, most products are used for the first two weeks after surgery. Eysuvis for dry eye is approved...
📖 Read our full Loteprednol Etabonate guide →

🕸️ Concept Web — How Loteprednol etabonate 10 MG/ML Ophthalmic Suspen... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Loteprednol etabonate 10 MG/ML Ophthalmic Suspension [Inveltys] RxCUI 2055286

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Loteprednol etabonate 52177
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Inveltys 2055282
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Loteprednol etabonate Ophthalmic Suspension 375144
    • Loteprednol etabonate Ophthalmic Product 1163869
    • Loteprednol etabonate Ophthalmic Suspension [Inveltys] 2055284
    • Inveltys Ophthalmic Product 2055285
    • Ophthalmic Suspension 316964
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Loteprednol etabonate 10 MG/ML [Inveltys] SBDC · 2055283
  • Loteprednol etabonate Ophthalmic Suspension [Inveltys] SBDF · 2055284
  • Inveltys Ophthalmic Product SBDG · 2055285
  • Inveltys BN · 2055282

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 2055286 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00065-9307-04 1 BOTTLE, DROPPER in 1 CARTON (0065-9307-04) / 2.8 mL in 1... Inveltys Alcon Laboratories, Inc. 2026-04-16
00065-9307-05 1 BOTTLE, DROPPER in 1 CARTON (0065-9307-05) / 2.8 mL in 1... Inveltys Alcon Laboratories, Inc. 2026-04-16
71571-0121-20 2.8 mL in 1 BOTTLE, DROPPER (71571-121-20) Inveltys ALCON LABORATORIES, INC. 2018-08-22
71571-0121-28 1 BOTTLE, DROPPER in 1 CARTON (71571-121-28) / 2.8 mL in 1... Inveltys ALCON LABORATORIES, INC. 2018-08-22
Observed labelers: Alcon Laboratories, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.